Indaptus Therapeutics

-$0.22 (-7.41%) Today
-$0.20 (-7.27%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell INDP and other ETFs, options, and stocks.

About INDP

Indaptus Therapeutics, Inc. is a pre-clinical biotechnology company, which engages in the development of a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It created patented treatment methods and associated patented compositions for attenuation and killing of non-pathogenic, Gram-negative bacteria.

CEO
Jeffrey A. Meckler
Employees
5
Headquarters
New York, New York
Founded
—

INDP Key Statistics

Market cap
22.71M
Price-Earnings ratio
—
Dividend yield
—
Average volume
2.71M
High today
$2.85
Low today
$2.30
Open price
$2.82
Volume
1.23M
52 Week high
$28.83
52 Week low
$2.13

INDP Earnings

-$5.53
-$3.69
-$1.84
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
-$0.83 per share
Actual
-$0.41 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure